Original protocol used in research article:
Adenovirus type 5 SARS-CoV-2 vaccines delivered orally or intranasally reduced disease severity and transmission in a hamster model
Science Translational Medicine, May 5, 2022; DOI:
10.1126/scitranslmed.abn6868